Article the Mechanisms and Therapeutic Potential of Clopidogrel in Mitigating Diabetic in Db/db Mice

Bing Li,Yaoting Zhang,Yang Zheng,He Cai
DOI: https://doi.org/10.1016/j.isci.2024.109134
IF: 5.8
2024-01-01
iScience
Abstract:Clopidogrel has been shown to play a protective role against diabetic nephropathy. However, whether clopidogrel exerts a protective effect against diabetic cardiomyopathy (DCM) is unknown. Threemonth -old male db/db mice were administered clopidogrel daily at doses of 5, 10, and 20 mg/kg by gavage for 5 months. Here, we showed that clopidogrel effectively attenuated diabetes -induced cardiac hypertrophy and cardiac dysfunction by inhibiting cardiac fibrosis, inflammatory responses, and oxidative stress damage in db/db mice. Diabetes -induced cardiac fibrosis was inhibited by clopidogrel treatment via blockade of the TGF-b1/Smad3/P2RY12 pathway and inhibition of macrophage infiltration in db/db mice. The protective effects of clopidogrel against oxidative damage were mediated by the induction of the Nrf2 signaling pathway. Taken together, our findings provide strong evidence that clopidogrel is a promising effective agent for the treatment of DCM by alleviating diabetesinduced cardiac hypertrophy and dysfunction. P2RY12 might be an effective target for the treatment of DCM.
What problem does this paper attempt to address?